¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"smooth muscle antibody"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® skeletal muscle ÇÑ±Û °ñ°Ý±Ù
¼³¸í   
  °ñ°Ý¿¡ ºÙ¾î ±× ¿îµ¿À» °üÀåÇϴ ±ÙÀ°°è. °ñ°Ý±Ù-ÆòȰ±Ù-½ÉÀå±Ù µî ¼¼ °³ ±ÙÁ¶Á÷ÀÇ Çϳª. ±½±â 10~100¥ì, ±æÀÌ 5~12cmÀÇ °¡´Ã°í ±ä ±ÙÀ°¼¶À¯ÀÇ ÁýÇÕüÀ̸ç, °¡·Î¹«´Ì°¡ ÀÖ°í, ¼öÀǿÀ» ÇÑ´Ù. ÇÑ °³ÀÇ °ñ°Ý±ÙÀº ´Ù¼öÀÇ ±Ù¼¶À¯¿Í °áÇÕÁ¶Á÷À¸·Î ±¸¼ºµÇ°í °¢±â Æ¯À¯ÇÑ ÇüŸ¦ Áö´Ñ´Ù. ±ÙÀ°ÀÇ ¾ç³¡Àº °¡´Ã¸ç ±× ºÎºÐÀ» ±ÙÀ°¸Ó¸®¶ó°í ÇÑ´Ù. ±ÙÀ°¸Ó¸®´Â ÈûÁٷΠÀÌÇàÇϸç ÈûÁÙÀº »À¸·¿¡ ºÙ´Âµ¥, ¶§·Î´Â »À¸·À» Œä°í »À¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. ±ÙÀ°ÀÇ Á߾Ӻδ ±½°í µÎ²¨¿ì¸ç À̺κÐÀ» ±Ùº¹À̶ó ÇÑ´Ù. ±ÙÀ°¸Ó¸®´Â ´Ù½Ã µÎ°¥·¡±Ù-¼¼°¥·¡±Ù-³×°¥·¡±ÙÀ¸·Î ³ª´¶´Ù. ±ÙÀ°ÀÇ ¿îµ¿ ÀÚü´Â Ç×»ó ±Ù¼¶À¯ÀÇ ¹æÇâ¿¡ µû¸£´Â ¼öÃà¿îµ¿»ÓÀÌ´Ù. ±×·¯³ª °ñ°Ý±ÙÀÌ »À¿¡ ºÙÀº À§Ä¡¿¡ µû¶ó »À´ë¿¡ ´ëÇÑ ¿©·¯ °¡Áö ¿îµ¿À» ÇϰԠµÈ´Ù. ¿îµ¿Çϴ ÇüÅ·Π°ñ°Ý±ÙÀ» ºÐ·ùÇÏ¸é Æï±Ù-±ÁÈû±Ù-³»Àü±Ù-¿ÜÀü±Ù-ȸ¿Ü±Ù-ȸ³»±Ù-¿Ã¸²±Ù µîÀÌ ÀÖ´Ù. ±ÁÈ÷°í Æï-³»¿ÜÀü-ȸ³»¿ÜÀÇ ¿îµ¿Àº °üÀýÃàÀ» Áß½ÉÀ¸·Î ÇàÇÑ´Ù. °°Àº °ñ°Ý¿¡ ´ëÇÏ¿© Æß±ÙÀ°°ú ±ÁÈû±ÙÀ°ÀÌ °¢±â ¹Ý´ë¿îµ¿À» ÇÒ °æ¿ì¿¡´Â ¾ç ±ÙÀ°À» ¼­·Î ´ëÇ×±ÙÀ̶ó Çϰí, °øµ¿¿îµ¿À» Çϴ °æ¿ì¿¡´Â °øµ¿±ÙÀ̶ó ÇÑ´Ù. 
¿µ¹® muscle ÇÑ±Û ±ÙÀ°
¼³¸í   
  ÀǽÄÀÇ Á¶Àý¿©ºÎ¿¡ µû¶ó ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁú ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ½ÉÀå±ÙÀÌ µû·Î Á¸ÀçÇÑ´Ù.
¿µ¹® muscle biopsy ÇÑ±Û ±ÙÀ°»ý°Ë
¼³¸í   
  »ýü³»¿¡¼­ ±ÙÀ°¿¡ ´ëÇÑ Áúº´ÀÇ °¨º°Áø´ÜÀ» À§Çؼ­ ½Ç½ÃÇϴ °Ë»ç¹ý. ¹æ¹ýÀº º´ÅͰ¡ Àִ ºÎÀ§³ª È¤Àº ¾ø¾îµµ Å©°Ô È°µ¿¿¡ ÁöÀåÀÌ ¾ø´Â ±ÙÀ°ºÎÀ§ÀÇ Á¶Á÷À» ¶¼¾î Çö¹Ì°æÀûÀ¸·Î °Ë»çÇÑ´Ù. ¿¹¸¦ µé¾î ½Å°æÁ¶Á÷ÀÇ ÀÌ»óÀ¸·Î ÀÎÇÑ ±ÙÀ°º´ÅÍÀÇ °æ¿ì, ±ÙÀ°»ý°ËÀ» ÇÏ¿© °üÂûÇØº¸¸é À̸¥¹Ù ¡°¹«¸®Áø À§Ãà(grouped atrophy)¡±ÀÌ ³ªÅ¸³ª¼­, ´Ù¸¥ º´ÅÍ¿¡ ÀÇÇÑ °Í°ú °¨º°ÀÌ °¡´ÉÇÏ´Ù.
¿µ¹® voluntary muscle ÇÑ±Û ¼öÀDZÙ
¼³¸í   
  ÀÇÁöÀÇ ÈûÀ¸·Î ¿òÁ÷ÀÏ ¼ö Àִ ±ÙÀ°. °ñ°Ý±Ù ¿Ü¿¡ ÇǺΠ³»ÀÇ ÇDZÙ, °üÀýÁÖ¸Ó´Ï¿¡ ºÎÂøÇϰí Àִ °üÀý±Ù µîÀÌ ¿©±â¿¡ ¼ÓÇÑ´Ù. ¼öÀDZÙÀÇ ±Ù¼¶À¯¿¡´Â °¡·Î¹«´Ì°¡ ÀÖÀ¸¹Ç·Î °¡·Î¹«´Ì±ÙÀ̶ó°íµµ Çϳª, ½ÉÀå±ÙÀº °¡·Î ¹«´Ì°¡ À־ ¼öÀDZÙÀÌ ¾Æ´Ï¹Ç·Î ¼öÀDZٰú °¡·Î¹«´Ì±ÙÀº µ¿ÀǾî´Â ¾Æ´Ï´Ù. ¼öÀDZÙÀÇ ¿îµ¿Àº ¹Î¹«´Ì±Ùº¸´Ù ºü¸£´Ù. ¼öÀDZÙÀ̶ó Çصµ °ñ°Ý±Ù µîÀº ±ÙÀ°¹«¸®·Î¼­ ¿òÁ÷ÀÏ ¼ö ÀÖÀ¸³ª, °³°³ÀÇ ±ÙÀ°Àº µû·Îµû·Î ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÒ ¼ö ¾ø´Ù. ±Ó¹ÙÄû±ÙÀ°Àº »ç¶÷ÀÇ °æ¿ì ¹ßÀ°ÀÌ ³ªºü ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÏ±â ¾î·Æ´Ù. 
¿µ¹® facial muscle ÇÑ±Û ¾ó±¼±ÙÀ°
¼³¸í   
  ¾ó±¼ÀÇ ÇǺθ¦ ¿òÁ÷À̰í ÀÌ¿¡ ºÎÂøµÇ¾î Àִ ¾ó±¼½Å°æÀÇ °ø±ÞÀ» ¹Þ´Â ¼ö¸¹Àº ±ÙÀ°À» Æ÷ÇÔÇϴ ¾ó±¼Ç¥Á¤±ÙÀ̳ª ¸ð¹æ±Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody removal
    Ç×üÁ¦°Å
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody synthesis
    Ç×üÇÕ¼º
  • antibody valence
    Ç×ü°áÇÕ°¡
  • antibody-binding site
    Ç×ü°áÇÕºÎÀ§
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î¼º
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antibody-producing cell
    Ç×ü»ý»ê¼¼Æ÷
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • anticardiolipin antibody
    Ç×Ä«µð¿À¸®ÇÉÇ×ü
  • anti-double stranded deoxyribonucleic acid antibody
    Ç×ÀÌÁß°¡´ÚDNAÇ×ü
  • anti-dsDNA antibody
    Ç×ÀÌÁß°¡´ÚDNAÇ×ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blocking antibody
    Â÷´ÜÇ×ü
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antibody synthesis
    Ç×üÇÕ¼º
  • antibody titer
    Ç×ü°¡
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • muscle disease
    ±ÙÀ°º´
  • muscle flap
    ±ÙÀ°ÆÇ, ±ÙÆÇ
  • red muscle fiber
    Àû»ö±ÙÀ°¼¶À¯, Àû»ö±ÙÀ°¼¼Æ÷
  • white muscle fiber
    ¹é»ö±ÙÀ°¼¶À¯, ¹é»ö±ÙÀ°¼¼Æ÷
  • muscle
    ±ÙÀ°
  • abdominal muscle
    ¹è±ÙÀ°, º¹±Ù
  • facial muscle
    ¾ó±¼±ÙÀ°
  • gastrocnemius muscle
    ÀåµýÁö±Ù
  • gluteus muscle
    º¼±â±Ù, µÐ±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibody excess
    Ç×ü°úÀ×
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • antibody removal
    Ç×üÁ¦°Å
  • antibody synthesis
    Ç×üÇÕ¼º
  • antibody titer
    Ç×ü°¡
  • antibody transfer
    Ç×üÀÌÀÔ
  • antibody valence
    Ç×ü°áÇÕ°¡
  • antibody absorption
    Ç×üÈíÂø
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤¹ý
  • antibody deficiency syndrome
    Ç×ü°áÇÌÁõÈıº
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀÓ±âÀü
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-binding site
    Ç×ü°áÇÕºÎÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • DF3 antibody
    DF3 Ç×ü
  • DL antobody => Donath-Landsteiner antibody
    DL Ç×ü
  • Donath-Landsteiner antibody
    µµ³ª¾²¶õÆ®½ºÅ¸ÀÌ³Ê Ç×ü
  • FTA (fluorescent treponemal antibody)
    ¸Åµ¶Çü±¤Ç×ü °Ë»ç¹ý
  • Fy antigen/antibody
    Fy Ç׿ø/Ç×ü
  • Gp 120/160 antibody
    Gp 120/160 Ç×ü
  • Gp 24 antibody
    Gp 24 Ç×ü
  • I antibody
    I Ç×ü
  • Jk antigen/antibody
    JkÇ׿ø/Ç×ü
  • Jo-1 antibody
    Jo-1 Ç×ü
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£Ç¥Çö
  • Lewis antibody
    ·çÀ̽ºÇ×ü
  • Lutheran antibody
    ·çÅ×¶õÇ×ü
  • M2 antibody
    M2 Çü Ç×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vascular smooth muscle cell
    ¸Æ°ü¼º ÆòȰ±Ù¼¼Æ÷
  • hamstring muscles ; biceps femoris muscle ; semitendineus muscle ; semi menbrabeus muscle ; sartori
    ½½¿ÍºÎ±ÙÀ°__
  • long peroneal muscle ; muscle peroneus longus ; muscle fibularis longus ?Àå ºñ°ñ±Ù.
  • short peroneal muscle ; muscle peroneus brevis ; muscle fibularis brevis
    ªÀººñ°ñ±Ù, ´Üºñ°ñ±Ù.
  • colony, smooth (S)
    Ȱ¸éÁý¶ô, ¸Å²öÇÑÁý¶ô, SÁý¶ô
  • smooth chorion
    ¹ÎÀ¶¸ð¸·, À¶¸ð¸·¹«¸ðºÎ(ëÖپدÙíپݻ).
  • smooth colony
    ½º¹«µåÁý¶ô(¡­ó¢Õª), SÁý¶ô.
  • smooth colony
    ½º¹«µåÁý¶ô(¡­ó¢Õª), SÁý¶ô.
  • smooth diet
    ¹«ÀڱؽÄÀÌ(Ùíô§Ð½ãÝìÈ).
  • smooth endoplasmic reticulum
    ¹«°ú¸³¼º³»ÇüÁú¼¼¸Á(ÇüÁú³»¼¼¸Á)(ÙíΨأàõ³»û¡òõá¬ØÑ(û¡òõ³»á¬ØÑ)
  • smooth muscles of urogenital duct
    ºñ´¢»ý½Ä°ü¹Î¹«´Ì±Ù
  • smooth musclular tissue
    ¹Î¹«´Ì±ÙÀ°Á¶Á÷ [³»Àå±ÙÀ°Á¶Á÷]
  • smooth muscular tissue
    ¹Î¹«´Ì±ÙÁ¶Á÷, ÆòȰ±ÙÁ¶Á÷(¡­ðÚòÄ).
  • smooth pursuit
    ¿øÈ°ÃßÁ¾¿îµ¿
  • smooth pursuit eye movement
    ¿øÈ°ÃßÁ¾¾È¿îµ¿
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Rectovesical muscle
    °ðâÀڹ汤±Ù
    [¿¾ ¿ë¾î] Á÷À广±¤±Ù
  • Rectourethral muscle
    °ðâÀÚ¿äµµ±Ù
    [¿¾ ¿ë¾î] Á÷Àå¿äµµ±Ù
  • Ischiocavernus muscle
    ±ÃµÕÇØ¸éü±Ù
    [¿¾ ¿ë¾î] Á°ñÇØ¸éü±Ù
  • Tragicus muscle
    ±Í±¸½½±Ù
    [¿¾ ¿ë¾î] ÀÌÁÖ±Ù
  • Transversus auricularis muscle
    ±Ó¹ÙÄû°¡·Î±Ù
    [¿¾ ¿ë¾î] À̰³È¾±Ù
  • Obliquus auricularis muscle
    ±Ó¹ÙÄûºø±Ù
    [¿¾ ¿ë¾î] À̰³»ç±Ù
  • Auricular pyramidal muscle
    ±Ó¹ÙÄûÇǶó¹Ô±Ù
    [¿¾ ¿ë¾î] À̰³Ãßü±Ù
  • Muscle fascicle
    ±ÙÀ°´Ù¹ß
    [¿¾ ¿ë¾î] ±Ù¼Ó
  • Muscle fiber
    ±ÙÀ°¼¶À¯
    [¿¾ ¿ë¾î] ±Ù¼¶À¯
  • Satellite cell of skeletal muscle
    ±ÙÀ°À§¼º¼¼Æ÷
    [¿¾ ¿ë¾î] ±ÙÀ§¼º¼¼Æ÷
  • Muscle layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Tracheal muscle
    ±â°ü±Ù
    [¿¾ ¿ë¾î] ±â°ü±Ù
  • Bronchial muscle
    ±â°üÁö±Ù
    [¿¾ ¿ë¾î] ±â°üÁö±Ù
  • Bronchoesophageal muscle
    ±â°üÁö½Äµµ±Ù
    [¿¾ ¿ë¾î] ±â°üÁö½Äµµ±Ù
  • Sulcus for flexor hallucis longus muscle
    ±ä¾öÁö±ÁÈû±ÙÈûÁÙ°í¶û
    [¿¾ ¿ë¾î] Àå¸ðÁö±¼±Ù°Ç±¸
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibody binding fraction
    Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
  • antibody combining site
    Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • antibody diversity
    Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
  • antibody fixation
    Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
  • antibody formation
    Ç×ü Çü¼º(ù÷ô÷û¡à÷)
  • antibody heterogeneity
    Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
  • antibody response
    Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
  • antibody specificity
    Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
  • antibody titer
    Ç×ü¿ª°¡(ù÷ô÷æ³Ê¤)
  • antibody valence
    Ç×ü°¡(ù÷ô÷ʤ)
  • antibody-excess zone
    Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
  • anticomplement fluorescent antibody technique
    Ç׺¸Ã¼ Çü±¤Ç×ü¼ú(ù÷ÜÍô÷û«ÎÃù÷ô÷âú)
  • antigen-antibody complex
    Ç׿øÇ×ü º¹ÇÕü(ù÷ê«ù÷ô÷ ÜÜùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gluteal muscle
    µÐ±ººÎ, µÐ±Ù
  • hamstring muscle
    ½½¿ÍºÎ±ÙÀ°
  • iliac muscle
    Àå°ñ±Ù
  • iliocostal muscle
    Àå°ñ´Á°ñ±Ù, Àå´Á±Ù
  • iliopsoas muscle
    Àå°ñÇ㸮±Ù, Àå¿ä±Ù
  • inferior rectus muscle
    ÇÏÁ÷±Ù
  • intercostal muscle
    ´Á°£±Ù
  • internal obturator muscle
    ³»Æó¼â±Ù
  • laryngeal muscle
    ÈĵαÙ
  • lateral pterygoid muscle
    ¿ÜÃøÀ͵¹±Ù
  • lateral rectus muscle
    ¿ÜÁ÷±Ù
  • levator muscle
    °Å±Ù
  • levator veli palatini muscle
    ±¸°³°Å±Ù
  • long head of biceps muscle of thigh
    ´ëÅðÀ̵αÙÀåµÎ
  • longus capitis muscle
    µÎÀå±Ù
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MR Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe...
SMA   1) Smooth Muscle Antibodies
  2) ô¼ö¼º ±ÙÀ§ÃàÁõ
  3) Superior Mesent...
ASMC arterial smooth muscle cell
BSMC bronchial smooth muscle cell
SM Master of Science; sadomasochism; self-monitoring; silicon microphysiometer; simple mastectomy; skim...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BSM Bronchial smooth muscle
HASM Human airway smooth muscle
haSMC Human arterial smooth muscle cell
HVSMC Human vascular smooth muscle cells
PASMC Pulmonary artery smooth muscle cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anti-intercellular substance antibody
    Ç×¼¼Æ÷°£ ¹°Áú Ç×ü
  • antibasement membrane antibody
    Ç×±âÀú¸· Ç×ü
  • antibody absorption
    Ç×ü ÈíÂø
  • antibody defect
    Ç×ü °á¼Õ
  • antibody dependent cell mediated cytotoxicity
    Ç×ü ÀÇÁ¸ ¼¼Æ÷ ¸Å°³ ¼¼Æ÷ µ¶¼º, Ç×ü ÀÇÁ¸¼º ¼¼Æ÷ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
  • antibody excess zone
    Ç×ü °úÀ׿ª
  • antibody half-life
    Ç×ü ¹Ý°¨±â
    Ç×ü ºÐÀÚ°¡ Çü¼ºµÈ ÈÄ Æò±Õ »ýÁ¸ÇÏ´Â ½Ã°£À» ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î¼­, º¸Åë µ¿¹°Ã¼³»¿¡¼­ ÀÏÁ¤·®ÀÇ ¸é¿ª ±Û·ÎºÒ¸°ÀÇ 50%¸¦ Á¦°ÅÇÏ´Â µ¥ °É¸®´Â ½Ã°£À¸·Î Ç¥½ÃÇÑ´Ù. ÀÌ ¹Ý°¨±â´Â ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù.
  • antibody response
    Ç×ü ¹ÝÀÀ
  • antibody synthesis
    Ç×ü »ý»ê, Ç×ü ÇÕ¼º
    µ¿ÀǾî=antibody
  • antibody titer
    Ç×ü ¿ª°¡
  • antibody-drug-cell complex
    Ç×ü ¾à¹° ¼¼Æ÷ º¹ÇÕü
  • antigen antibody complex
    Ç׿ø Ç×ü º¹ÇÕü
    Ç׿ø°ú Ç×ü°¡ °áÇÕÇÑ °Í. ¸é¿ª º¹ÇÕü¶ó°íµµ ÇÑ´Ù. Ç×ü´Â Ç׿ø°ú °áÇÕÇÏ¿© º¹ÇÕü¸¦ ¸¸µé¸é º¸Ã¼ Ȱ¼ºÈ­ ÀÛ¿ëÀ» °¡Áö°Ô µÈ´Ù. ±×·¡¼­ »ýü ³»¿¡¼­ ¸é¿ª º¹ÇÕü°¡ Çü¼ºµÇ¸é ±× ÁÖº¯¿¡¼­ ºÎü°¡ Ȱ¼ºÈ­µÇ¾î ¿°Áõ¹ÝÀÀÀ» ¹ß»ý½ÃŰ´Â ¼ÀÀÌ´Ù. Ç׿ø Ç×ü º¹ÇÕü´Â ħ°­¼ºÀÇ °ÍÀ¸·Î µÇ±â ½±´Ù. µû¶ó¼­ Ç׿øÀÇ Ä§ÀÔ ºÎÀ§¿¡ ¿°Áõ¹ÝÀÀÀÌ »ý±â±â ½±´Ù.
  • antigen antibody reaction
    Ç׿ø Ç×ü ¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿ø-Ç×ü ¹ÝÀÀ
  • antiglobulin antibody
    Çױ۷κθ° Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
smooth muscular sphincter A sphincter of smooth musculature.
Synonym: smooth muscular sphincter.
Origin: G. Lissos, smooth, + sphincter
(05 Mar 2000)
smooth strain <microbiology> Bacterial strains that have altered outer cell wall carbohydrate chains causing colonies on agar to change their appearance from smooth to dull.
In Streptococci the smooth strains are virulent whereas the rough strains are not. This is partly because the rough strains are much more readily phagocytosed.
(17 Dec 1997)
smooth surface caries Caries initiated on the smooth surfaces of teeth.
(05 Mar 2000)
smooth-surfaced endoplasmic reticulum Endoplasmic reticulum that is lacking in ribosomal granules; involved in synthesis of complex lipids and fatty acids, detoxification of drugs, carbohydrate synthesis, and sequestering of Ca++.
Synonym: smooth-surfaced endoplasmic reticulum.
(05 Mar 2000)
endoplasmic reticulum, smooth A type of endoplasmic reticulum lacking associated ribosomes on the membrane surface. It exhibits a wide range of specialised metabolic functions including supplying enzymes for steroid synthesis, detoxification, and glycogen breakdown. In muscle cells, smooth endoplasmic reticulum is called sarcoplasmic reticulum.
(12 Dec 1998)
affinity antibody The measure of the interaction between molecules such as a receptor and its ligand. This interaction is reversible.
(05 Mar 2000)
agglutinating antibody 1. An antibody that causes clumping or agglutination of the bacteria or other cells which either stimulated the formation of the agglutinin, or contain immunologically similar, reactive antigen.
Synonym: agglutinating antibody, immune agglutinin.
2. A substance, other than a specific agglutinating antibody, that causes organic particles to agglutinate, commonly qualified, e.g., plant agglutinin.
(05 Mar 2000)
anaphylactic antibody Antibody that has an affinity for certain kinds of cells, in addition to and unrelated to its specific affinity for the antigen that induced it, because of the properties of the Fc portion of the heavy chain.
See: heterocytotropic antibody, homocytotropic antibody, cytotropic antibody test.
Synonym: anaphylactic antibody, cytophilic antibody.
(05 Mar 2000)
anti-basement membrane antibody Autoantibodies to renal glomerular basement membrane antigens.
(05 Mar 2000)
antibody An immunoglobulin molecule that has a specific amino acid sequence by virtue of which it interacts only with the antigen that induced its synthesis in cells of the lymphoid series (especially plasma cells) or with antigen closely related to it. Antibodies are classified according to their ode of action as agglutinins, bacteriolysins, haemolysins, opsonins, precipitins, etc.
(18 Nov 1997)
antibody affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
(12 Dec 1998)
antibody aldolase <enzyme> Prepared by reactive immuninization to catalyze a wide variety of aldol reactions and decarboxylations
Registry number: EC 4.1.2.-
Synonym: fab 33f12, aldolase catalytic antibody
(26 Jun 1999)
antibody-coated bacteria test, urinary Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.
(12 Dec 1998)
antibody combining site <immunology> In immune network theory, an idiotope, an antigenic site of an antibody that is responsible for that antibody binding to an antigenic determinant (epitope).
Also used of the site on a ligand molecule to which a cell surface receptor binds.
(18 Nov 1997)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á